Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus

A B Milsom, C J H Jones, J Goodfellow, M P Frenneaux, J R Peters, P E James

Research output: Contribution to journalArticlepeer-review

63 Citations (Scopus)


Reduced bioavailability of endothelium-derived nitric oxide is implicated in diabetic macrovascular and microvascular disease. In patients with diabetes, we hypothesised that protein glycosylation can alter nitric oxide binding affinity of haemoglobin and plasma proteins, hence reducing nitric oxide availability and causing an alteration in nitric oxide metabolism.
Original languageEnglish
Pages (from-to)1515-22
Number of pages8
Issue number11
Publication statusPublished - Nov 2002


  • Adult
  • Age of Onset
  • Biological Availability
  • Blood Glucose
  • Blood Specimen Collection
  • Cholesterol
  • Diabetes Mellitus, Type 1
  • Electron Spin Resonance Spectroscopy
  • Glycosylation
  • Hemoglobin A, Glycosylated
  • Hemoglobins
  • Humans
  • Kinetics
  • Nitrates
  • Nitric Oxide
  • Nitrites
  • Triglycerides

Cite this